| Year | 2026 |
|---|---|
| Code | 8631 |
| Main Department | Department of Pharmacy and Biotechnology |
| Campus | Bologna |
| Credits | 3 |
| Cost | 100,00 € |
| Application deadline | Jun 24, 2026 |
- Subject area
- Sciences and technology
- Learning outcomes
- The Summer School, which will last for 5 days, will be taught in English. It awards 3 University educational credits (CFU) and has as its learning outcome In the last decade we have witnessed changes in the design and conduction of research in the biomedical field, resulting from the decoding of the human genome. In particular , it is relevant that the revolution has been focused on the discovery of new drugs and new drug targets thanks to genomics, transcriptomics and proteomics. The selection and validation of new drug targets requires a number of research strategies that have been developed recently. The aim of the School is to spread among young people in education and among those who are already working in this field, how to best use the tools offered by the most advanced research and updated . Experts, leaders in their field, were invited as lecturers. They will explain, through lectures and a lab exercise, the following topics: chemogenomics, drug discovery, genomics; the role of high-throughput assays; the small interfering RNA; reporter gene models in vitro and in vivo; transcription factors as new therapeutic targets; chemiluminescence Integrated systems for analysis. Finally, we will sketch the lines of the future development of these technologies. In order to better facilitate the dialogue between teachers and students, there are two moments in the middle and at the end of the course, in which students will be encouraged to ask teachers questions on the topics that most interested them. Another highlight will be the individual experience in the laboratory, where each student will engage in experiments planned under the guidance of specialized tutor.
- Number of participants
- minimum 8 maximum 50
- Duration
- 5 days
- Language
- English
- Admission qualifications
- All applicants must hold the following qualifications and meet the following admission requirements by the enrolment end date 24 June 2026:
- Bachelor and/or two-year Master degrees awarded pursuant to Ministerial Decree 270/04 (or first-cycle and/or second-cycle degrees awarded under the degree programme systems in force prior to Ministerial
Decree DM 509/99) in the following disciplinary areas/degree programme classes: L-2 Biotechnologies, Genomics, L-13 Biology, L-29 Pharmacy,LM-6 Biology, LM-8 Industrial Biotechnologies, LM-9
Pharmaceutical, Veterinary and Medical biotechnologies, LM-13 Pharmacy and industrial pharmacy, LM-41 Medicine, LM-54 Chemistry;
- Bachelor and/or two-year Master degrees awarded abroad in the above-said disciplinary areas and valid for admission to the Programme;
- Students enrolled in the 4th years of LM13.
- Study plan
- Biased agonism at GPCRs , integrin and neurodegenerative disease - BIOS-11A
- Bioinformatics - BIO/16
- HIV Therapeutic Strategies - MED/17
- Genetic and epigenetic pathways in drug discovery: Nuclear receptors as pharmacologicaltargets - BIO/10
- Probing Allosteric Communication with Combined Molecular Dynamics Simulations and Network Analysis - CHIM/08